Form 4: Sotera Health CFO's RSU Vesting & Tax Withholding

Sotera Health's CFO, Jonathan M. Lyons, reported the withholding of 11,508 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Summary

• Jonathan M. Lyons, Senior Vice President and CFO of Sotera Health Co (SHC), reported a transaction on August 5, 2025.
• 11,508 shares of Common Stock were disposed of at a price of $11.19 per share.
• This disposal was due to shares being withheld by Sotera Health to satisfy tax withholding obligations upon the vesting of 25,655 Restricted Stock Units (RSUs).
• The vested RSUs represent 33% of an RSU award granted to Mr. Lyons on August 7, 2023, under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Following this transaction, Mr. Lyons directly beneficially owns 189,602 shares of Common Stock.
• Mr. Lyons also holds 81,676 stock options granted on March 4, 2024, with an exercise price of $14.59, vesting annually in three equal installments starting March 2, 2025.
• Additionally, he holds 33,640 stock options granted on August 7, 2023, with an exercise price of $16.89, vesting annually in three equal installments starting August 5, 2024.
• He also holds a maximum of 29,895 performance-based RSUs granted on March 3, 2025, subject to stock price-related performance conditions, generally vesting annually in 60%, 20%, and 20% installments commencing March 3, 2026.

Sentiment

Score: 7

Explanation: The filing reflects a routine executive compensation event (RSU vesting and tax withholding) and the continued long-term incentive alignment of a key executive through stock options and performance RSUs. This is generally a neutral to slightly positive signal as it indicates executive retention and ongoing equity participation.

Positives

• Vesting of Restricted Stock Units indicates achievement of performance or service conditions.
• Continued beneficial ownership of a significant number of shares (189,602) by a key executive.
• Granting of additional stock options and performance RSUs aligns executive incentives with shareholder value.
• Transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction.

Negatives

• Disposal of shares, although for tax purposes, reduces direct beneficial ownership.

Future Outlook

The vesting schedules for stock options and performance-based RSUs extend into 2025 and 2026, indicating continued long-term incentive alignment for the Senior Vice President and CFO, subject to continued service and performance conditions.

Industry Context

This Form 4 filing is a routine disclosure of executive compensation and share ownership changes, common across all publicly traded companies. It does not provide specific insights into broader industry trends or competitive landscape beyond the company's internal compensation practices.

Stakeholder Impact

• Shareholders: The filing indicates continued alignment of executive incentives with shareholder interests through equity awards. The disposal for tax withholding is a standard, non-discretionary event.
• Employees: The filing pertains to executive compensation and does not directly impact the broader employee base, though it reflects the company's incentive plan structure.

Next Steps

• Annual vesting of 81,676 stock options commencing March 2, 2025.
• Annual vesting of 33,640 stock options commencing August 5, 2024.
• Annual vesting of 29,895 performance-based RSUs commencing March 3, 2026, subject to performance.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the vesting of Restricted Stock Units and the subsequent withholding of shares for tax purposes, along with the ongoing vesting schedules for other equity awards. It does not present new information that would fundamentally alter the investment thesis for Sotera Health. The transaction is expected and reflects standard executive incentive alignment rather than a discretionary sale or purchase based on new material information. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a change in investment stance.

Keywords

Sotera Health, SHC, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units, Stock Options, Tax Withholding, Beneficial Ownership, Jonathan Lyons, SEC Filing